|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at the Thomas Weisel Partners Healthcare Tailwinds 2004 Conference|
BOULDER, Colo., Aug. 25 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Thomas Weisel Partners Healthcare Tailwinds 2004 Conference on September 10 in Boston. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: Thomas Weisel Partners Healthcare Tailwinds 2004 Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Friday, September 10, 2004 Time: 9:10 am Eastern Time Location: The Four Seasons Hotel, Boston Audio Webcast: www.arraybiopharma.com About Array BioPharma:
Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.